Vaxil Enters Into a Cooperative Research and Development Agreement With U.S. Army Medical Research Institute of Infectious Diseases (“USAMRIID”)

Ads

You May Also Like

Aduro Biotech Provides Update on CRS-207 Programs

BERKELEY, Calif., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical ...

Dr. Richard D. Katz Joins Argos Therapeutics as Chief Financial Officer

DURHAM, N.C., July 11, 2016 (GLOBE NEWSWIRE) -- Argos Therapeutics, Inc. (Nasdaq:ARGS), an immuno-oncology ...